FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a compound of formula l
in the form of a salt wherein W means a group of formula 
and A means acetate or xinafoate, as well as to based pharmaceutical compositions which may be used for treating the diseases accompanied by bronchospasms.
EFFECT: what is offered is a new effective bronchial spasmolytic.
7 cl, 23 ex, 4 tbl, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS, METHOD FOR PREPARING COMPOUND, PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2244709C2 |
| METHOD OF PRODUCTION OF 5-[(R)-2-(5,6-DIETHYLINDAN-2-YLAMINO)-1-HYDROXYETHYL]-8-HYDROXY-(1H)-QUINOLIN-2-ONE SALT WHICH IS USEFUL AS ADRENORECEPTOR AGONIST | 2004 |
|
RU2332405C2 |
| COMBINATIONS OF GLUCOPYRROLATE AND B-2 ADRENOCEPTOR ANTOGONISTS | 2005 |
|
RU2388465C2 |
| ENANTIOSELECTIVE METHOD FOR SYNTHESIS OF QUINOLINE DERIVATIVES | 2005 |
|
RU2383534C2 |
| METHOD OF OBTAINING 5-( α -HALOGEN ACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLINE-2-ONS | 2004 |
|
RU2339621C2 |
| ORGANIC COMPOUNDS | 2001 |
|
RU2292890C2 |
| CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS | 2010 |
|
RU2533122C2 |
| INHALATION MEDICINES CONTAINING BETA-MEMETICS AND ANTICHOLINERGIC AGENT | 2004 |
|
RU2375059C2 |
| APPLICATION OF TIOTROPIUM SALTS FOR TREATMENT OF SEVERE FORMS OF PERSISTENT ASTHMA | 2006 |
|
RU2422144C2 |
| NEW DOSE AND FORMULATION | 2009 |
|
RU2608713C2 |
